Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Melinta Therapeutics, Inc. (MLNTQ) had Receiveable Turnover of 0.84 for the most recently reported fiscal quarter, ending 2019-09-30.
| Income Statement Financials | |
$15.87M |
|
$-213.38M |
|
$8.21M |
|
$7.66M |
|
$216.05M |
|
$-200.18M |
|
$-13.20M |
|
$-213.38M |
|
$-213.38M |
|
$-213.38M |
|
$-213.38M |
|
$-213.38M |
|
$-213.38M |
|
$-200.18M |
|
$-195.92M |
|
13.62M |
|
13.62M |
|
$-15.67 |
|
$-15.67 |
|
| Balance Sheet Financials | |
$131.27M |
|
$1.17M |
|
$97.22M |
|
$228.49M |
|
$128.05M |
|
$152.79M |
|
$160.97M |
|
$289.02M |
|
$-60.53M |
|
$-100.63M |
|
$-60.53M |
|
13.75M |
|
| Cash Flow Statement Financials | |
$-89.82M |
|
$-1.22M |
|
$72.75M |
|
$82.01M |
|
$63.72M |
|
$-18.29M |
|
$1.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.03 |
|
-- |
|
-- |
|
1.66 |
|
-2.52 |
|
48.25% |
|
-1261.38% |
|
-1261.38% |
|
-- |
|
-1344.56% |
|
-1344.56% |
|
$-89.83M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.21 |
|
|
Receiveable Turnover |
0.84 |
107.37 |
|
352.52% |
|
212.04% |
|
-93.39% |
|
-231.28% |
|
$-4.40 |
|
$-6.60 |
|
$-6.60 |
|